OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting KRASG12C-Mutated Advanced Colorectal Cancer: Research and Clinical Developments
Jingran Ji, Chongkai Wang, Marwan Fakih
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 747-756
Open Access | Times Cited: 26
Jingran Ji, Chongkai Wang, Marwan Fakih
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 747-756
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Pharmacogenomics: Driving Personalized Medicine
Wolfgang Sadée, Daqing Wang, Katherine E. Hartmann, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 4, pp. 789-814
Open Access | Times Cited: 79
Wolfgang Sadée, Daqing Wang, Katherine E. Hartmann, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 4, pp. 789-814
Open Access | Times Cited: 79
Recent Advancements, Limitations, and Future Perspectives of the use of Personalized Medicine in Treatment of Colon Cancer
Amit Dey, Abhijit Mitra, Surajit Pathak, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 50
Amit Dey, Abhijit Mitra, Surajit Pathak, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 50
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
Yasutoshi Kuboki, Marwan Fakih, John H. Strickler, et al.
Nature Medicine (2024) Vol. 30, Iss. 1, pp. 265-270
Open Access | Times Cited: 34
Yasutoshi Kuboki, Marwan Fakih, John H. Strickler, et al.
Nature Medicine (2024) Vol. 30, Iss. 1, pp. 265-270
Open Access | Times Cited: 34
Circular RNAs in the KRAS pathway: Emerging players in cancer progression
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155259-155259
Closed Access | Times Cited: 12
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155259-155259
Closed Access | Times Cited: 12
Connecting the Dots: LncRNAs in the KRAS Pathway and Cancer
Mudasir Maqbool, Md Sadique Hussain, Ajay Singh Bisht, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155570-155570
Closed Access | Times Cited: 10
Mudasir Maqbool, Md Sadique Hussain, Ajay Singh Bisht, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155570-155570
Closed Access | Times Cited: 10
KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics
Ioannis A. Voutsadakis
Critical Reviews in Oncology/Hematology (2023) Vol. 186, pp. 103987-103987
Closed Access | Times Cited: 15
Ioannis A. Voutsadakis
Critical Reviews in Oncology/Hematology (2023) Vol. 186, pp. 103987-103987
Closed Access | Times Cited: 15
Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review
Fernand Bteich, Mahshid Mohammadi, T. Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12030-12030
Open Access | Times Cited: 14
Fernand Bteich, Mahshid Mohammadi, T. Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12030-12030
Open Access | Times Cited: 14
Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer
Lindor Qunaj, Michael May, Alfred I. Neugut, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 14
Lindor Qunaj, Michael May, Alfred I. Neugut, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 14
Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer
Wei Ye, Lu Xin, Yue Qiao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189108-189108
Closed Access | Times Cited: 5
Wei Ye, Lu Xin, Yue Qiao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189108-189108
Closed Access | Times Cited: 5
Progress of KRAS G12C inhibitors in the treatment of refractory colorectal cancer and strategies for drug resistance response
Peiyuan Yang, Yongchao Li
Investigational New Drugs (2025)
Closed Access
Peiyuan Yang, Yongchao Li
Investigational New Drugs (2025)
Closed Access
KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy
Priyanka Uniyal, Vivek K. Kashyap, Tapan Behl, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 785-785
Open Access
Priyanka Uniyal, Vivek K. Kashyap, Tapan Behl, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 785-785
Open Access
Impact of carbamazepine on SMARCA4 (BRG1) expression in colorectal cancer: modulation by KRAS mutation status
Aaron Shaykevich, Danbee Chae, Isaac Silverman, et al.
Investigational New Drugs (2024) Vol. 42, Iss. 2, pp. 229-239
Open Access | Times Cited: 3
Aaron Shaykevich, Danbee Chae, Isaac Silverman, et al.
Investigational New Drugs (2024) Vol. 42, Iss. 2, pp. 229-239
Open Access | Times Cited: 3
Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective
Alberto Puccini, Andreas Seeber, Martin D. Berger
Cancers (2022) Vol. 14, Iss. 19, pp. 4828-4828
Open Access | Times Cited: 15
Alberto Puccini, Andreas Seeber, Martin D. Berger
Cancers (2022) Vol. 14, Iss. 19, pp. 4828-4828
Open Access | Times Cited: 15
Molecular Landscape and Therapeutic Strategies against Colorectal Cancer
Aakash Patel, Pat Gulhati
Cancers (2024) Vol. 16, Iss. 8, pp. 1551-1551
Open Access | Times Cited: 2
Aakash Patel, Pat Gulhati
Cancers (2024) Vol. 16, Iss. 8, pp. 1551-1551
Open Access | Times Cited: 2
Assessment of KRASG12C inhibitors for colorectal cancer
Gary A. Piazza, Preethi Chandrasekaran, Yulia Maxuitenko, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Gary A. Piazza, Preethi Chandrasekaran, Yulia Maxuitenko, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
The effects of KRAS Mutations on the Prognosis of Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Surgery
Ji Sun Park, Soon Seong Lee, Youn Seon Choi
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 7, pp. 2337-2342
Open Access | Times Cited: 1
Ji Sun Park, Soon Seong Lee, Youn Seon Choi
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 7, pp. 2337-2342
Open Access | Times Cited: 1
Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers
Patrick Loi, Amy E. Schade, Carrie L. Rodriguez, et al.
Cancer Discovery (2024) Vol. 14, Iss. 12, pp. 2430-2449
Open Access | Times Cited: 1
Patrick Loi, Amy E. Schade, Carrie L. Rodriguez, et al.
Cancer Discovery (2024) Vol. 14, Iss. 12, pp. 2430-2449
Open Access | Times Cited: 1
From Subtypes to Solutions: Integrating CMS Classification with Precision Therapeutics in Colorectal Cancer
Xinyi Ding, Hao Huang, Fang Zhang, et al.
Current Treatment Options in Oncology (2024)
Closed Access | Times Cited: 1
Xinyi Ding, Hao Huang, Fang Zhang, et al.
Current Treatment Options in Oncology (2024)
Closed Access | Times Cited: 1
Evaluation of AMG510 Therapy on KRAS-Mutant Non–Small Cell Lung Cancer and Colorectal Cancer Cell Using a 3D Invasive Tumor Spheroid System under Normoxia and Hypoxia
Meng Huang, Wei Hou, Jing Zhang, et al.
Bioengineering (2022) Vol. 9, Iss. 12, pp. 792-792
Open Access | Times Cited: 5
Meng Huang, Wei Hou, Jing Zhang, et al.
Bioengineering (2022) Vol. 9, Iss. 12, pp. 792-792
Open Access | Times Cited: 5
Sensitivities and Dependencies of BRAF Mutant Colorectal Cancer Cell Lines with or without PIK3CA Mutations for Discovery of Vulnerabilities with Therapeutic Potential
Ioannis A. Voutsadakis
Medicina (2022) Vol. 58, Iss. 10, pp. 1498-1498
Open Access | Times Cited: 3
Ioannis A. Voutsadakis
Medicina (2022) Vol. 58, Iss. 10, pp. 1498-1498
Open Access | Times Cited: 3
Recent updates of clinical trials for colorectal cancer
Vipul Prajapati, Salona Roy, Shraddha Shinde, et al.
Elsevier eBooks (2024), pp. 411-456
Closed Access
Vipul Prajapati, Salona Roy, Shraddha Shinde, et al.
Elsevier eBooks (2024), pp. 411-456
Closed Access
Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcomes in solid tumors
Priyanka Sahu, Ankita Mitra, Anirban Ganguly
International review of cell and molecular biology (2024), pp. 167-222
Closed Access
Priyanka Sahu, Ankita Mitra, Anirban Ganguly
International review of cell and molecular biology (2024), pp. 167-222
Closed Access
Integrated molecular profiling of RAS, BRAF mutations, and mismatch repair status in advanced colorectal carcinoma: insights from gender and tumor laterality
Gabriela Remonatto, Emily Ferreira Salles Pilar, Fernanda de Paris, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 4, pp. 1580-1591
Open Access
Gabriela Remonatto, Emily Ferreira Salles Pilar, Fernanda de Paris, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 4, pp. 1580-1591
Open Access
Insight of the molecular mechanism of inhibitors located at different allosteric sites regulating the activity of wild type and mutant KRAS (G12)
Ye Liu, Yan Li, Guohui Li, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 760, pp. 110137-110137
Closed Access
Ye Liu, Yan Li, Guohui Li, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 760, pp. 110137-110137
Closed Access
Mechanisms of treatment resistance in colorectal cancer
Benny Mosoane, Georgios Lolas, Zodwa Dlamini
Elsevier eBooks (2024), pp. 25-40
Closed Access
Benny Mosoane, Georgios Lolas, Zodwa Dlamini
Elsevier eBooks (2024), pp. 25-40
Closed Access
